TWO SIGMA ADVISERS, LP - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 120 filers reported holding CARA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.01 and the average weighting 0.5%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$230,832
-36.4%
137,400
+7.2%
0.00%0.0%
Q2 2023$362,806
+185.3%
128,200
+395.0%
0.00%
Q1 2023$127,169
-18.0%
25,900
+52.4%
0.00%
Q2 2022$155,000
-27.9%
17,000
-4.0%
0.00%
-100.0%
Q1 2022$215,000
-79.6%
17,700
-74.0%
0.00%
-66.7%
Q3 2021$1,052,000
-72.2%
68,100
-74.4%
0.00%
-70.0%
Q2 2021$3,789,000
-53.8%
265,500
-29.7%
0.01%
-56.5%
Q1 2021$8,200,000
+102.9%
377,700
+41.4%
0.02%
+109.1%
Q4 2020$4,041,000
+33.7%
267,100
+12.5%
0.01%
+22.2%
Q3 2020$3,022,000
+77.8%
237,500
+138.9%
0.01%
+80.0%
Q2 2020$1,700,000
+472.4%
99,400
+341.8%
0.01%
+400.0%
Q1 2020$297,000
-12.1%
22,500
+7.1%
0.00%0.0%
Q4 2019$338,000
+31.0%
21,000
+48.9%
0.00%0.0%
Q3 2019$258,000
-64.8%
14,100
-62.2%
0.00%
-50.0%
Q1 2019$732,000
+42.1%
37,300
-5.8%
0.00%
+100.0%
Q4 2018$515,000
+13.7%
39,600
+109.5%
0.00%0.0%
Q3 2018$453,000
+128.8%
18,900
+16.7%
0.00%0.0%
Q4 2017$198,000
-15.4%
16,200
-5.3%
0.00%0.0%
Q3 2017$234,000
+8.8%
17,100
+22.1%
0.00%0.0%
Q2 2017$215,000
+133.7%
14,000
-5.4%
0.00%0.0%
Q1 2016$92,000
-66.3%
14,800
-20.9%
0.00%
-50.0%
Q3 2015$273,00018,7000.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Ridgeback Capital Investments L.P. 622,140$10,489,00045.13%
RHO CAPITAL PARTNERS INC 2,668,057$44,983,00015.47%
Opaleye Management Inc. 427,000$7,199,0003.01%
DAFNA Capital Management LLC 169,331$2,855,0002.54%
Private Capital Advisors, Inc. 246,850$4,162,0001.80%
WALL STREET ASSOCIATES 192,300$3,242,0000.91%
SECTORAL ASSET MANAGEMENT INC 1,212,578$20,444,0000.87%
Virtus ETF Advisers LLC 17,299$292,0000.80%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 618,140$10,422,0000.58%
SPHERA FUNDS MANAGEMENT LTD. 197,820$3,335,0000.49%
View complete list of CARA THERAPEUTICS INC shareholders